BioLife Plasma Services
The Business Lead, AI-native Small Molecule Discovery owns Takeda's next-generation small molecule discovery AI-native software products, defining the scientific vision, product strategy, and roadmap to drive adoption and measurable value. This foundational leadership role acts as the business owner for the small molecule discovery product family, translating strategic vision into AI-enabled discovery workflows and ensuring products are scientifically grounded and technically actionable. The position requires deep expertise in small molecule discovery combined with computational, data, and technology fluency to lead cross-functional teams and shape the future-state Labs of Tomorrow capabilities.
Headquarters
Bannockburn, Illinois, United States
Company Size
5001-10000 employees
BioLife Plasma Services operates a network of plasma collection centers that collect donated human plasma used to manufacture life‑saving plasma‑derived therapies. The company focuses on donor safety and convenience, offering screening, regulated collection procedures, appointment scheduling, and compensation/rewards to encourage repeat donations. BioLife partners with biopharmaceutical manufacturers and maintains rigorous quality and regulatory standards to supply plasma for treatments such as immune deficiencies, bleeding disorders, and other therapeutic uses.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for BioLife Plasma Services.
Director, Molecular Discovery
Lila Sciences
Scientific Fellow, AI-Enabled Molecular Design - all genders
sanofi us
Head of Small Molecule Discovery
Elanco
Scientific Fellow, AI-Enabled Molecular Design
sanofi us
Chemistry Department Leader
Sartorius
Scientific Leader, Integrated Medicinal Chemistry, Computational Chemistry, Cheminformatics and DMPK
Relay Therapeutics